Co-Authors
This is a "connection" page, showing publications co-authored by Paul Ruff and Oluwatosin Ayeni.
Connection Strength
1,980
-
Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Res. 2023 01 23; 25(1):7.
Score: 0,217
-
The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Res Treat. 2023 Feb; 197(3):647-659.
Score: 0,216
-
Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Int J Cancer. 2022 Jul 15; 151(2):209-221.
Score: 0,204
-
The multimorbidity profile of South African women newly diagnosed with breast cancer. Int J Cancer. 2020 07 15; 147(2):361-374.
Score: 0,174
-
A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern Africa. J Pain Symptom Manage. 2019 05; 57(5):923-932.
Score: 0,165
-
Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa. Cancer Manag Res. 2018; 10:279-286.
Score: 0,154
-
Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiol. 2018 02; 52:120-127.
Score: 0,153
-
Perspectives on common chronic diseases in adult cancer patients in South Africa. Glob Health Action. 2023 12 31; 16(1):2228567.
Score: 0,058
-
The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches. PLOS Glob Public Health. 2023; 3(10):e0002432.
Score: 0,057
-
FGFR2 genetic variants in women with breast cancer. Mol Med Rep. 2023 Dec; 28(6).
Score: 0,057
-
The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. Oncologist. 2023 10 03; 28(10):e921-e929.
Score: 0,057
-
Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clin Pharmacol Ther. 2023 07; 114(1):127-136.
Score: 0,055
-
Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLoS One. 2023; 18(2):e0281916.
Score: 0,055
-
The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. Oncologist. 2022 03 11; 27(3):e233-e243.
Score: 0,051
-
Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa. Breast Cancer Res Treat. 2021 Aug; 189(1):285-296.
Score: 0,049
-
Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast Units. JCO Glob Oncol. 2021 01; 7:72-80.
Score: 0,047
-
A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection. Breast Cancer Res Treat. 2020 Dec; 184(3):861-872.
Score: 0,046
-
Spiritual Care, Pain Reduction, and Preferred Place of Death Among Advanced Cancer Patients in Soweto, South Africa. J Pain Symptom Manage. 2020 07; 60(1):37-47.
Score: 0,044
-
Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures. J Glob Oncol. 2019 11; 5:1-16.
Score: 0,043
-
Barriers to early presentation of breast cancer among women in Soweto, South Africa. PLoS One. 2018; 13(2):e0192071.
Score: 0,039
-
Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS One. 2017; 12(8):e0182125.
Score: 0,037